B cells, fundamental in adaptive immunity, exhibit the capacity to differentiate into regulatory B cells (Bregs). This specific group of B cells, recognized by their unique patterns of cytokine release ... addressing…
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, comprising approximately 25-30% of adult non-Hodgkin lymphomas in western countries and consists ... into distinct molecular…
LCLs) and in a subset of Burkitt lymphoma (BL) lines characterized by an activated B cell phenotype and a unique latent EBV gene expression pattern (latency III). In these cells ... products in switching on or…
This lecture will address the alteration of B-cell receptor (BCR) signaling in B-cell from lymphomas such as Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma
after BCR activation (Ingham et al. 2001). FOXP1 is a transcription factor crucial for B cell development and implicated in progression of B-cell lymphomas (Hu et al. 2006). Silencing ... GAB1 or FOXP1 decreased the…
several inflammatory rheumatic diseases (IRD). Though clinical trials have shown some efficacy of B-cell depletion in ankylosing spondylitis (AS), results are less convincing. Other studies have revealed an association…
B cell neoplasms comprise >50% of blood cancers. However, many types of B cell malignancies remain incurable. Identification and validation of novel genetic risk factors and oncogenic signaling pathways ... B…
DPPIV) is a multifunctional membrane protein and it is strongly upregulated in activated B-cells. We aimed to evaluate CD26 expression in mature B cell neoplasms, and its prognostic role ... B cell chronic lymphocytic…
hematopoietic differentiation of stem cells into mature lymphocytes. Developmental control of early B lineage cell differentiation is exerted by a regulatory network of key transcription factors. The high frequency…
Objective: To present a case of Disseminated Intravascular Large B-cell Lymphoma presenting as fever of unknown origin. Method: Case Report Background: Intravascular large B-cell lymphoma (IVLBCL ... expired due to…
Background:Diffuse Large B cell Lymphoma (DLBCL) accounts for approximately 25% of all Non-Hodgkin’s lymphoma (NHL) in the developed world, making it the most common lymphoma. With
Lymphoid Tissues (2017 WHO) has created several new provisional entities of high-grade B-cell lymphomas, including Burkitt-like lymphoma with 11q aberration, high grade B-cell lymphoma, not otherwise ... specified…
CHOP) versus placebo plus R-CHOP chemotherapy in subjects with previously untreated activated B-cell (ABC) type Diffuse Large B-cell Lymphoma (DLBCL). The most commonly utilized immunohistochemistry (IHC) algorithm…
maintain homeostasis. This review explores the intricate mechanisms by which macrophages, dendritic cells, and B cells identify and respond to antigens. Macrophages, through their phagocytic activity and pattern…
food proteins and commensal microorganisms. Central to mucosal immunity are T cells and B cells, which orchestrate both defense and tolerance mechanisms. T-cell responses in the mucosal environment involve…
cases of these cells, previously "restricted" to adult T leukemia, have been reported in B-cells lymphomas, many of them highly aggressive. Thus, this brief article aims to show ... should be the assessment of these…